Long-Term Effects of Campylobacteriosis in Infants

Background. Campylobacteriosis is the leading cause of bloody diarrhea worldwide. Infants have high risk severe campylobacteriosis as well as development of complications affecting the child growth and development. Objective. The aim of the study is to evaluate the long-term effects of campylobacteriosis in infants. Methods. A multicenter, prospective, dynamic, open, observational study included 80 children aged from 3 months to 2 years. The follow-up period after campylobacteriosis was 12 months. Patients were divided into three groups according to the feeding type: 1 — acidified milk formulas, 2 — non-acidified milk formula without a probiotic, 3 — breastfeeding. Physical examination data and anthropometric indicators were evaluated: height, body weight and z-indices. Moreover, qualitative and quantitative indicators of microbiocenosis were evaluated on the 21st day from the disease onset. Results. Functional gastrointestinal disorders (FGID) were diagnosed in 17 children (42.50%) at the follow-up period after campylobacteriosis: functional constipation (n = 11; 27.5%), functional diarrhea (n = 3; 7.50%), infantile colic (n = 2; 5.00%), cyclic vomiting syndrome (n = 1; 2.50%). Disorders of intestinal microbiocenosis were characterized by Bifidobacterium spp. and B. thetaiotaomicron decrease in all groups. Patients with FGID after campylobacteriosis had profound decrease in the level of Bifidobacterium spp., F. prausnitzii and B. thetaiotaomicron, and slower rate of body weight gain. The more profound decrease in body weight gain rates was observed in patients with initially low indicators. 10 (25.00%) patients after campylobacteriosis had no slowdown in body weight gain. 5 of them were administered with acidified milk formula during the convalescence period. 7 children (17.5%) had a decrease in weight-to-age ratio relevant to body weight deficiency, while 6 children (15.0%) moreover had malnutrition in BMI-to-age index significantly more frequently (p = 0.0050) with non-acidified milk formula without a probiotic after completion of the follow-up. Conclusion. The inclusion of children on formula feeding in the complex of therapeutic measures (with acidified milk formulas with probiotics) contributes to the improvement of qualitative and quantitative indicators of microbiocenosis and the rapid restoration of the body weight gain and growth rates.

1. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015;28(3):687–720. doi: https://doi.org/10.1128/CMR.00006-15

2. Cribb DM, Varrone L, Wallace RL, et al. Risk factors for campylobacteriosis in Australia: outcomes of a 2018–2019 case-control study. BMC Infect Dis. 2022;22(1):586. doi: https://doi.org/10.1186/s12879-022-07553-6

3. Behtereva MK, Nirkova OI, Sizemov AN. Campylobacteriosis. Pediatrician. 2012;3(3):102–109. (In Russ).

4. Potapova TV, Lioznov DA, Drap AS, Ermolenko KD. Epidemiological and clinical and laboratory aspects of campilobacteriosis. Farmateka. 2017;5(13):40–43. (In Russ).

5. Gorelov AV. Campilobacteriosis in children. Infectious Diseases. 2004;2(3): 80–82. (In Russ).

6. Samie A, Moropeng RC, Tanih NF, et al. Epidemiology of Campylobacter infections among children of 0–24 months of age in South Africa. Arch Public Health. 2022;80(1):107. doi: https://doi.org/10.1186/s13690-022-00850-1

7. Tenkate T, Stafford R. Risk factors for campylobacter infection in infants and young children: a matched case-control study. Epidemiol Infect. 2001;127(3):399–404. doi: https://doi.org/10.1017/s0950268801006306

8. Ermolenko КD. Possibilities of prediction of сampylobacteriosis adverse outcomes in children. Detskie Infektsii = Children’s Infections. 2023;22(1): 14–18. (In Russ). doi: https://doi.org/10.22627/2072-8107-2023-22-1-14-18

9. MAL-ED Network Investigators. Relationship between growth and illness, enteropathogens and dietary intakes in the first 2 years of life: findings from the MAL-ED birth cohort study. BMJ Glob Health. 2017;2(4):e000370. doi: https://doi.org/10.1136/bmjgh-2017-000370

10. do Nascimento Veras H, Medeiros PH, Ribeiro SA, et al. Campylobacter jejuni virulence genes and immune-inflammatory biomarkers association with growth impairment in children from Northeastern Brazil. Eur J Clin Microbiol Infect Dis. 2018;37(10): 2011–2020. doi: https://doi.org/10.1007/s10096-018-3337-0

11. Ermolenko KD, Martens EA, Boldyreva NP, Ermolenko EI. Rational therapy for campylobacteriosis in children. Farmateka. 2019;26(10):40–44. (In Russ). doi: https://doi.org/10.18565/pharmateca.2019.10.40-44

12. Bekhtereva MK, Anokhin VA, Khaliullina SV. Klinicheskie rekomendatsii (protokol lecheniya) okazaniya meditsinskoi pomoshchi detyam, bol’nym kampilobakteriozom. 2018. (In Russ).

13. Benninga MA, Nurko S, Faure C, et al. Childhood functional gastrointestinal disorders: neonate/toddler. Gastroenterology. 2016:S0016-5085(16)00182-7. doi: https://doi.org/10.1053/j.gastro.2016.02.016

14. Belmer SV, Volynets GV, Gorelov AV, et al. Functional digestive disorders in children. Guidelines of Society of Pediatric Gastroenterologists, Hepatologists and Nutritionists. Part 1. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics. 2020;65:(4):150–161 (In Russ). doi: https://doi.org/10.21508/10274065-2020-65-4-150-161

15. de Onis M, Onyango A, Borghi E, et al. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization; 2006.

16. Mitakakis TZ, Wolfe R, Sinclair MI, et al. Dietary intake and domestic food preparation and handling as risk factors for gastroenteritis: a case-control study. Epidemiol Infect. 2004;132(4):601–606. doi: https://doi.org/10.1017/s0950268804002365

17. Jungersen M, Wind A, Johansen E, et al. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12. Microorganisms. 2014;2(2):92–110. doi: https://doi.org/10.3390/microorganisms2020092

18. Morrow A, Ruiz-Palacios G, Altaye M, et al. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Adv Exp Med Biol. 2004:554:443–446. doi: https://doi.org/10.1007/978-1-4757-4242-8_61

19. Tikhomirova OI, Skripchenko NV, Bekhtereva MK, Kirilenko LA. Rezul’taty aprobatsii smesei “NAN” i “NAN kislomolochnyi” pri ostrykh kishechnykh infektsiyakh u detei rannego vozrasta. Pediatric Nutrition. 2004;2(4):56–59. (In Russ).

20. Hossain MI, Nasrin S, Das R, et al. Symptomatic and Asymptomatic Campylobacter Infections and Child Growth in South Asia: Analyzing Data from the Global Enteric Multicenter Study. Am J Trop Med Hyg. 2023;108(6):1204–1211. doi: https://doi.org/10.4269/ajtmh.22-0347

21. Sung J, Morales W, Kim G, et al. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes. Neurogastroenterol Motil. 2013;25(6):529–537. doi: https://doi.org/10.1111/nmo.12118

22. Li H, Chen H, Wang J, et al. Influence of microplastics on the growth and the intestinal microbiota composition of brine shrimp. Front Microbiol. 2021;12:717272. doi: https://doi.org/10.3389/fmicb.2021.717272

23. Lee G, Pan W, Peñataro Yori P, et al. Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children. PLoS Negl Trop Dis. 2013;7(1):e2036. doi: https://doi.org/10.1371/journal.pntd.0002036

24. Bian X, Garber JM, Cooper KK, et al. Campylobacter abundance in breastfed infants and identification of a new species in the global enterics multicenter study. mSphere. 2020;5(1):e00735-19. doi: https://doi.org/10.1128/mSphere.00735-19

25. Childs CE, Röytiö H, Alhoniemi E, et al. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study. Br J Nutr. 2014;111(11):1945–1956. doi: https://doi.org/10.1017/S0007114513004261

26. Bomhof MR, Saha DC, Reid DT, et al. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity (Silver Spring). 2014;22(3): 763–771. doi: https://doi.org/10.1002/oby.20632

27. Wiredu Ocansey DK, Hang S, Yuan X, et al. The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease. Gut Microbes. 2023;15(1):2176118. doi: https://doi.org/10.1080/19490976.2023.2176118